AbCellera Biologics Inc. ( ABCL) - Stock Earnings
ABCL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -8.9 million USD | 44.9 million USD |
| 2026Q1 | -43.2 million USD | 8.3 million USD |
| 2026Q2 | -55.4 million USD | 4.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ABCL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -146.4 million USD | 38.0 million USD |
| 2024 | -162.9 million USD | 28.8 million USD |
| 2025 | -146.4 million USD | 75.1 million USD |
| 2026 Est. | — | — |
ABCL
Price: $13.92
52 week price:
Earnings Per Share: -0.73 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 1.3 million
Market Capitalization: 3.5 billion